A multicenter ... study to demonstrate the short and long-term safety of Elidel (pimecrolimus) cream 1% in the treatment of mild to moderate atopic dermatitis in infants
|Effective start/end date||1/20/04 → 4/1/11|
- NOVARTIS PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.